Literature DB >> 20368443

Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers.

Sara K Alford1, Edwin J R van Beek, Geoffrey McLennan, Eric A Hoffman.   

Abstract

Recent evidence suggests that endothelial dysfunction and pathology of pulmonary vascular responses may serve as a precursor to smoking-associated emphysema. Although it is known that emphysematous destruction leads to vasculature changes, less is known about early regional vascular dysfunction which may contribute to and precede emphysematous changes. We sought to test the hypothesis, via multidetector row CT (MDCT) perfusion imaging, that smokers showing early signs of emphysema susceptibility have a greater heterogeneity in regional perfusion parameters than emphysema-free smokers and persons who had never smoked (NS). Assuming that all smokers have a consistent inflammatory response, increased perfusion heterogeneity in emphysema-susceptible smokers would be consistent with the notion that these subjects may have the inability to block hypoxic vasoconstriction in patchy, small regions of inflammation. Dynamic ECG-gated MDCT perfusion scans with a central bolus injection of contrast were acquired in 17 NS, 12 smokers with normal CT imaging studies (SNI), and 12 smokers with subtle CT findings of centrilobular emphysema (SCE). All subjects had normal spirometry. Quantitative image analysis determined regional perfusion parameters, pulmonary blood flow (PBF), and mean transit time (MTT). Mean and coefficient of variation were calculated, and statistical differences were assessed with one-way ANOVA. MDCT-based MTT and PBF measurements demonstrate globally increased heterogeneity in SCE subjects compared with NS and SNI subjects but demonstrate similarity between NS and SNI subjects. These findings demonstrate a functional lung-imaging measure that provides a more mechanistically oriented phenotype that differentiates smokers with and without evidence of emphysema susceptibility.

Entities:  

Mesh:

Year:  2010        PMID: 20368443      PMCID: PMC2867701          DOI: 10.1073/pnas.0913880107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

2.  Topographical distribution of pulmonary perfusion and ventilation, assessed by PET in supine and prone humans.

Authors:  Guido Musch; J Dominick H Layfield; R Scott Harris; Marcos F Vidal Melo; Tilo Winkler; Ronald J Callahan; Alan J Fischman; Jose G Venegas
Journal:  J Appl Physiol (1985)       Date:  2002-11

3.  Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests.

Authors:  Martine Remy-Jardin; Jean-Louis Edme; Charles Boulenguez; Jacques Remy; Ioana Mastora; Annie Sobaszek
Journal:  Radiology       Date:  2002-01       Impact factor: 11.105

4.  The shrinking heart in chronic obstructive pulmonary disease.

Authors:  Anton Vonk-Noordegraaf
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

Review 5.  Quantitative assessment of airway remodeling using high-resolution CT.

Authors:  Yasutaka Nakano; Nestor L Müller; Gregory G King; Akio Niimi; Steven E Kalloger; Michiaki Mishima; Peter D Paré
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

7.  Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Hiroshi Kanazawa; Kazuhisa Asai; Kazuto Hirata; Junichi Yoshikawa
Journal:  Am J Med       Date:  2003-04-01       Impact factor: 4.965

Review 8.  What drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease?

Authors:  James C Hogg; John E McDonough; John V Gosselink; Shizu Hayashi
Journal:  Proc Am Thorac Soc       Date:  2009-12

9.  Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Authors:  R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

10.  Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease.

Authors:  Harvey O Coxson
Journal:  Proc Am Thorac Soc       Date:  2008-12-15
View more
  41 in total

Review 1.  Lung imaging in asthmatic patients: the picture is clearer.

Authors:  Mario Castro; Sean B Fain; Eric A Hoffman; David S Gierada; Serpil C Erzurum; Sally Wenzel
Journal:  J Allergy Clin Immunol       Date:  2011-06-02       Impact factor: 10.793

Review 2.  Quantitative pulmonary imaging using computed tomography and magnetic resonance imaging.

Authors:  George R Washko; Grace Parraga; Harvey O Coxson
Journal:  Respirology       Date:  2012-04       Impact factor: 6.424

Review 3.  Imaging lung perfusion.

Authors:  Susan R Hopkins; Mark O Wielpütz; Hans-Ulrich Kauczor
Journal:  J Appl Physiol (1985)       Date:  2012-05-17

4.  Preclinical vascular disease identifies smokers at risk for COPD.

Authors:  James D Crapo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-04       Impact factor: 11.205

Review 5.  The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease.

Authors:  Wassim W Labaki; Carlos H Martinez; Fernando J Martinez; Craig J Galbán; Brian D Ross; George R Washko; R Graham Barr; Elizabeth A Regan; Harvey O Coxson; Eric A Hoffman; John D Newell; Douglas Curran-Everett; James C Hogg; James D Crapo; David A Lynch; Ella A Kazerooni; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

6.  The Road to Precision Medicine in Chronic Obstructive Pulmonary Disease: Squeezing More Out of Chest Computed Tomography Scans.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Ann Am Thorac Soc       Date:  2018-04

7.  Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.

Authors:  Katja Hueper; Jens Vogel-Claussen; Megha A Parikh; John H M Austin; David A Bluemke; James Carr; Jiwoong Choi; Thomas A Goldstein; Antoinette S Gomes; Eric A Hoffman; Steven M Kawut; Joao Lima; Erin D Michos; Wendy S Post; Ming Jack Po; Martin R Prince; Kiang Liu; Dan Rabinowitz; Jan Skrok; Ben M Smith; Karol Watson; Youbing Yin; Alan M Zambeli-Ljepovic; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

8.  Arterial input function placement effect on computed tomography lung perfusion maps.

Authors:  Laura Jimenez-Juan; Hatem Mehrez; Chris Dey; Shabnam Homampour; Anastasia Oikonomou; Fatima Ursani; Narinder Paul
Journal:  Quant Imaging Med Surg       Date:  2016-02

9.  Lung perfusion characteristics in pulmonary arterial hypertension (PAH) and peripheral forms of chronic thromboembolic pulmonary hypertension (pCTEPH): Dual-energy CT experience in 31 patients.

Authors:  Jessica Giordano; Suonita Khung; Alain Duhamel; Claude Hossein-Foucher; Dimitri Bellèvre; Nicolas Lamblin; Jacques Remy; Martine Remy-Jardin
Journal:  Eur Radiol       Date:  2016-08-01       Impact factor: 5.315

10.  Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance.

Authors:  Stephen J Ives; Ryan A Harris; Melissa A H Witman; Anette S Fjeldstad; Ryan S Garten; John McDaniel; D Walter Wray; Russell S Richardson
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.